Wearable Healthcare Devices Market Demand | Strong Pipeline to Rapidly Surge Growth

The Wearable Healthcare Devices Market Demand is expected to grow rapidly, with a CAGR of 13% from 2022 to 2032. The market is expected to be worth US$ 30 billion by 2026, up from US$ 16 billion in 2021. The global wearable healthcare devices industry is estimated to be valued roughly US$ 61 billion by the end of 2032, representing a 3.8X increase over the current scenario.

Factors driving market growth include rising chronic illness prevalence, technical improvements in wearable medical devices, increased health awareness, and rising patient demand for real-time monitoring of key indicators. During the forecast period, the rising mortality rate from cardiovascular disorders such as diabetes, obesity, heart attacks, and stroke is likely to drive demand for wearable medical devices. According to the World Health Organisation, CVDs caused over 17.9 million deaths in 2019, with heart attacks and stroke accounting for 85% of those deaths.

Key Manufacturers in the Wearable Healthcare Devices Market:

Medtronic PLC, Koninklijke Philips N.V, GE Healthcare, Fitbit Inc, OMRON Corporation, Abbott Laboratories, Garmin Ltd., Dexcom Inc., and Masimo Corporation. 

Browse Detail Summary Of Research Report@ https://www.futuremarketinsights.com/reports/wearable-healthcare-devices-market

Key Segments

By Product:

  • Trackers
  • Smartwatches
  • Pathes
  • Smart Clothing

By Application:

  • General Health and Fitness
  • Remote Patient Monitoring
  • Home Healthcare

By Device Type:

  • Diagnostic and Monitoring Devices
  • Vital Sign Monitoring Devices
  • ECG/Heart Rate Monitors
  • Blood Pressure Monitors
  • Wrist Actigraphs
  • Polysomnography Devices
  • Traditional Diagnostic Tests

By Grade Type:

  • Consumer-grade Wearable Healthcare Devices
  • Clinical-grade Wearable Healthcare Devices

By Distribution Channel:

  • Pharmacies
  • Online Channel
  • Hypermarkets

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more